Evolution Advisers’s Biogen BIIB Stock Holding History

Evolution Advisers’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Buy	+1	New	+$191	﹤0.01%	290

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Evolution Advisers's BIIB Position: Q2 2026 in Review

Evolution Advisers opened a new position in Biogen (BIIB) in Q2 2026: 1 share worth $0. The stake represents ﹤0.01% of the portfolio and ranks #290 among its holdings.

1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Evolution Advisers held 1 share of Biogen worth $0 as of Q2 2026.
Biogen was a new Evolution Advisers position in Q2 2026.
Biogen made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #290 holding.
1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.